Correlation Between Esperion Therapeutics and ACELYRIN, INC
Can any of the company-specific risk be diversified away by investing in both Esperion Therapeutics and ACELYRIN, INC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Esperion Therapeutics and ACELYRIN, INC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Esperion Therapeutics and ACELYRIN, INC Common, you can compare the effects of market volatilities on Esperion Therapeutics and ACELYRIN, INC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Esperion Therapeutics with a short position of ACELYRIN, INC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Esperion Therapeutics and ACELYRIN, INC.
Diversification Opportunities for Esperion Therapeutics and ACELYRIN, INC
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Esperion and ACELYRIN, is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Esperion Therapeutics and ACELYRIN, INC Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ACELYRIN, INC Common and Esperion Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Esperion Therapeutics are associated (or correlated) with ACELYRIN, INC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ACELYRIN, INC Common has no effect on the direction of Esperion Therapeutics i.e., Esperion Therapeutics and ACELYRIN, INC go up and down completely randomly.
Pair Corralation between Esperion Therapeutics and ACELYRIN, INC
Given the investment horizon of 90 days Esperion Therapeutics is expected to generate 0.98 times more return on investment than ACELYRIN, INC. However, Esperion Therapeutics is 1.02 times less risky than ACELYRIN, INC. It trades about 0.07 of its potential returns per unit of risk. ACELYRIN, INC Common is currently generating about -0.07 per unit of risk. If you would invest 148.00 in Esperion Therapeutics on September 12, 2024 and sell it today you would earn a total of 156.00 from holding Esperion Therapeutics or generate 105.41% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Esperion Therapeutics vs. ACELYRIN, INC Common
Performance |
| Timeline |
| Esperion Therapeutics |
| ACELYRIN, INC Common |
Esperion Therapeutics and ACELYRIN, INC Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Esperion Therapeutics and ACELYRIN, INC
The main advantage of trading using opposite Esperion Therapeutics and ACELYRIN, INC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Esperion Therapeutics position performs unexpectedly, ACELYRIN, INC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ACELYRIN, INC will offset losses from the drop in ACELYRIN, INC's long position.| Esperion Therapeutics vs. Evoke Pharma | Esperion Therapeutics vs. Lantheus Holdings | Esperion Therapeutics vs. ANI Pharmaceuticals | Esperion Therapeutics vs. Ironwood Pharmaceuticals |
| ACELYRIN, INC vs. Ecolab Inc | ACELYRIN, INC vs. Boot Barn Holdings | ACELYRIN, INC vs. Burlington Stores | ACELYRIN, INC vs. Hawkins |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |